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The structure of the complex between hen egg-white lysozyme
and the Fab HyHEL-5 at 2.7 A˚ resolution has previously been
reported [Cohen et al. (1996), Acta Cryst. D52, 315–326]. With
the availability of recombinant Fab, the X-ray structure of the
complex has been re-evaluated at 1.7 A˚ resolution. The
refined structure has yielded a detailed picture of the Fab–
lysozyme interface, showing the high complementarity of the
protein surfaces as well as several water molecules within the
interface that complete the good fit. The model of the full
complex has improved significantly, yielding an Rwork of
19.5%. With this model, the structural results can be compared
with the results of isothermal titration calorimetry. An attempt
has been made to estimate the changes in bound waters that
accompany complex formation and the difficulties inherent in
using the crystal structures to provide the information
necessary to make this calculation are discussed.
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1. Introduction
Most protein molecules carry out their functions either in a
permanent or temporary association with other proteins.
These complexes range from simple homodimers to large
arrays and their structures reveal the nature of the specificity
of interaction and the forces involved in forming these asso-
ciations. Antibody complexes with protein antigens, an
essential part of the immune system, are being increasingly
studied as examples of simple dimeric complexes. Since both
antibodies and their protein antigens when uncomplexed are
soluble proteins, their interacting surfaces are likely to be
reasonably polar in character and, when isolated, would be in
contact with a layer of bound water molecules. The analysis of
several such complexes has demonstrated the relative contri-
butions of shape complementarity, hydrogen bonding and the
role of interfacial waters in determining the specificity of the
antibody–antigen interaction (Bhat et al., 1994; Braden et al.,
1994, 1998; Chacko et al., 1995, 1996; Cohen et al., 1996;
Dall’Aqua et al., 1998; Fields et al., 1996; Kondo et al., 1999;
Lawrence & Colman, 1993; Malby et al., 1994; Monaco-Malbet
et al., 2000; Mylvaganam et al., 1998; Tulip et al., 1992; Yili et al.,
2000, 2003).
The structure of the antibody–antigen complex of
HyHEL-5 Fab with lysozyme has been investigated previously
by X-ray crystallography (Cohen et al., 1996) and by other
experimental and computational studies (Xavier et al., 1997;
Xavier & Willson, 1998; Wibbenmeyer, Schuck et al., 1999).
The earlier X-ray studies of the complex were performed with
Fab that was proteolytically derived from the intact antibody.
†
†
Here, we report a study of the HyHEL-5 complex with lyso-
zyme using recombinant Fab for which the individual chains
have been cloned and expressed in Escherichia coli
(Wibbenmeyer, Xavier et al., 1999). These crystals diffract
significantly better than the original crystals, permitting a
credible location of the water molecules in the interacting
surfaces and providing a basis for estimating the change in
bound waters when the two proteins interact. Contrary to
naive expectation, several groups have reported an increase in
the number of bound waters as a result of complex formation
(Xavier et al., 1997). In this report, we present crystallographic
results regarding the number of waters involved in the
antigen–antibody interface of the complex. We also discuss
some of the potential pitfalls in estimating the change in the
number of waters in this interface in comparison with the
number of waters associated with the same surfaces of the
uncomplexed antigen and antibody.
2. Methods
Recombinant HyHEL-5 Fab protein was prepared as
described in Wibbenmeyer, Xavier et al. (1999). Crystals of the
complex of the Fab with lysozyme were prepared as described
previously for the proteolytically cleaved Fab (Sheriff,
Silverton et al., 1987). The crystals obtained are of the so-
called ‘long-axis’ form found in previous work, with unit-cell
parameters a = 54.46, b = 74.26, c = 78.26 A˚,  = 101.6 and
space group P21. Diffraction data to 1.7 A˚ were collected at
95 K on an R-AXIS I system. Data were processed with the
HKL program suite (Otwinowski & Minor, 1997), yielding the
statistics shown in Table 1.
The earlier model for the complex (PDB code 3hfl; Cohen et
al., 1996), with water molecules removed, served as the
starting point of the refinement. Rigid-body refinement
(X-PLOR v.3.1; Bru¨nger, 1992) using 10.0–3.0 A˚ data with
Fobs 2.0(F) on the lysozyme, the Fv domain and the CL:CH1
domain resulted in an R factor of 0.34. Alternating cycles of
model building and structure refinement were performed,
initially using data only to 2.5 A˚, then gradually including
more data until all reflections to 1.7 A˚ were used. Model
building was accomplished using the program O (Jones et al.,
1991) with 2Fo  Fc and Fo  Fc maps. Initial model refine-
ment was performed with data having Fobs  3.0(F), with
alternate simulated-annealing positional and thermal factor
cycles and the parameter set of Engh & Huber (1991) in
X-PLOR. A test set of 5% randomly chosen reflections was
used for the calculation of Rfree (Bru¨nger, 1997). Solvent
molecules were located automatically from Fo Fc maps using
MAPMAN (Kleywegt & Jones, 1996) at various stages of the
refinement and confirmed with X-PLOR as well as by visual
inspection. CNS v.1.0 (Bru¨nger et al., 1998) was subsequently
employed using overall anisotropic temperature-factor
correction, a bulk-solvent mask, maximum-likelihood target
correction and all non-negative diffraction data. Final vali-
dation and location of water sites was carried out with CNS,
using procedures provided in the program suite with standard
parameters followed by visual inspection. Solvent molecules
with high thermal factors were individually examined and
removed unless they appeared to be involved in reasonable
contacts with protein. Candidate solvent molecules that were
not reasonably near protein or that were not located in density
in a 2Fo  Fc map were also removed.
Molecular comparisons were carried out using ALIGN
(Cohen, 1997). Surface calculations and the study of cavities
and interfaces were made with the MS program suite
(Connolly, 1983) and CONTACSYM (Sheriff, Hendrickson et
al., 1987) using a probe radius of 1.5 A˚. Shape comple-
mentarity, Sc, a measure that approaches 1.0 when a pair of
surfaces has a constant ‘ideal’ separation throughout with
normals that are antiparallel, was calculated by the method of
Lawrence & Colman (1993).
2.1. Model quality
Refinement statistics are shown in Table 1. The stereo-
chemistry of this model is significantly better than that of the
previous model. Only one non-glycine residue falls in a
disallowed ’, region, Thr51L. The ’, angles for this residue
of CDR L2 identify it as a class 3 -turn (Milner-White & Poet,
1987), consistent with L2 of other Fab light chains (Milner-
White et al., 1988).
During refinement, a sequence error was discovered in the
PDB models 2hfl and 3hfl. Two residues in positions 199–200
of CH1 that had initially been assigned as Pro-Arg were
corrected to Thr-Trp, in agreement with the DNA sequence.
This correction also improved the fit in the maps for 3hfl.
The cloned sequence (Wibbenmeyer, Xavier et al., 1999)
differs in several residues from the sequence of Kabat et al.
(1987). In both the light and heavy chains a methionine has
been inserted prior to the first residue; the next residue of VH
is Glu in place of pyroglutamate. The electron-density maps
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Table 1
Summary of crystallographic data.
Values in parentheses refer to the highest resolution shell.
Space group P21
Unit-cell parameters a = 54.46, b = 74.26, c = 78.26,
 = 90,  = 101.6,  = 90
Oscillation data collected on 185 1.0 images at 95 K
Wavelength (A˚) 1.542 (Cu K)
Resolution range (A˚) 30–1.7 (1.74–1.7)
Observed reflections 117428 (3428)
Independent reflections 62951 (2767)
Completeness (%) 94 (58)
I/(I) 16.3 (1.9)
Rsym (%) 5.5 (29.4)
Refinement using CNS
Resolution range (A˚) 30–1.7 (1.78–1.7)
Completeness
Working set (%) 84 (53)
Free set (%) 4 (3)
Rwork (%) 19.5 (29.1)
Rfree (%) 23.4 (27.5)
No. of residues 555
No. of water molecules 619
Geometry: r.m.s. deviations
Bond lengths (A˚) 0.005
Bond angles () 1.29
reveal the methionine of the light chain but not of the heavy
chain. At the end of CH1 the cloned sequence terminates at
residue Ile223. Following that, the Leu-Asp beginning of the
His6 tag at the end of CH1 (Leu-Asp-His-His-His-His-His-His)
is clear in the maps. The maps also provide a hint of the first of
the His residues, but the remaining ones cannot be seen with
confidence.
As previously identified (Cohen et al., 1996), proline resi-
dues Pro8L, Pro141L, Pro149H, Pro151H and Pro202H are all in
the cis confirmation. Four residues in the loop joining the first
two strands of CH1, 128, 129, 130 and 133, are in poor density
in the electron-density maps; they have been modeled
primarily according to stereochemical considerations. Six
residues, 22, 24, 29, 72 and 106 of VL, and 62 of the bound
lysozyme molecule, have been modeled as disordered with two
side-chain rotamers, each having an occupancy of 0.5. The final
model contains 619 water molecules.
3. Results
3.1. The Fab-lysozyme interface
We define the antibody–lysozyme interface residues as
those residues of the antibody and lysozyme whose van der
Waals surfaces come within 3.0 A˚ of each other as calculated
by the MS program suite. The total buried surface area is
1337 A˚2, discounting water molecules. There are two solvent-
inaccessible cavities between the two interacting surfaces that
are occupied by two water molecules each. Three additional
buried waters are located at other sites within the interface.
An additional 63 water molecules are associated with the
interface and its periphery, increasing the total buried surface
area to 1933 A˚2.
A significant feature in the interface is the presence of salt
bridges involving Glu50H with Arg45Y and Arg68Y. The
importance of these salt bridges in stabilizing the HyHEL-5–
lysozyme complex has been established through isothermal
titration calorimetry (Wibbenmeyer, Schuck et al., 1999) and is
consistent with the previously reported structure of the
complex and with the complex formed by HyHEL-5 with
bobwhite quail lysozyme (Chacko et al., 1996).
We find 70 water molecules located near to the interface of
the HyHEL-5–lysozyme complex. As noted above, seven of
these waters are buried in the interface between the lysozyme
and the antibody and are inaccessible to solvent. Seven others
are in solvent-accessible channels that penetrate a few
angstroms into the interface between the lysozyme and the
Fab. The remaining 56 are on the periphery of the interface
and extend the effective size of the interface beyond that of
the protein–protein contact alone. There are 13 protein–
protein hydrogen bonds, 11 water molecules involved in
protein–water–protein hydrogen bonds, 25 water molecules
positioned to provide 18 hydrogen-bond bridges of the form
protein–water–water–protein, three hydrogen-bond bridges
involving three water molecules each and a number of van der
Waals contacts. The water molecules associated with and
bridging the interface have an average temperature factor that
is slightly below the average temperature factor of the
complete set of 619 waters in the structure. The interface and
its vicinity also contains side-chain stacking and water mole-
cule to aromatic ring hydrogen bonding (Fig. 1); one such
hydrogen bond is part of the cross-interface hydrogen
bonding.
An analysis of the interface using CONTACSYM shows
that 19 residues from the Fab, representing all six CDR
regions, are in contact with 13 lysozyme residues. When the
bridging waters are included in the analysis of the interface
interactions, an additional four Fab residues and two lysozyme
residues become indirectly involved in the interface through
the water molecules. We have added these six residues to the
interface that was originally calculated in the absence of water.
All potential hydrogen-bond donors and acceptors within the
interface are satisfied either by direct contact across the
interface or through the associated waters.
The antibody–antigen interface was also examined by
evaluating its shape complementarity, Sc. Lawrence & Colman
(1993) defined this measure to reflect the physical fit between
the surfaces of two components of a protein assembly. As an
example of the measure, the then current early model of the
HyHEL-5–lysozyme complex (PDB code 2hfl) was included
along with several other antibody–antigen complexes as one
class of interfaces (Table 1 of Lawrence & Colman, 1993).
They noted consistently lower values of Sc for antigen–anti-
body interfaces in comparison to Sc for protein–protein inhi-
bitor and oligomeric interfaces. They propose that this
relatively poorer interface match may arise from the need for
this type of interface to adapt its fit as needed. With our later
model, PDB code 3hfl, as well as our current model, we find
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Figure 1
Detailed view of the interactions between seven residues involved in the
contacts between the bound lysozyme and the HyHEL-5 antibody. Two
residues from lysozyme are shown with blue bonds, two residues from the
antibody light chain are shown with yellow bonds and three residues from
the heavy chain are shown with green bonds. Hydrogen bonding is shown
with thin black bonds. The electron density from a 2Fo  Fc map is
contoured at 1.8. The diagram was prepared with Ribbons v.3.12
(Carson, 1997).
that this observation may have an alternative explanation. The
magnitudes of Sc, in the absence of waters, for the complex
interfaces of 2hfl, 3hfl and the current model are 0.646, 0.712
and 0.719, respectively. The values for 3hfl and the current
model are in the same range as most of the other models in
Table 1 of Lawrence & Colman (1993), suggesting that the
apparent low values for the antibody–antigen interfaces noted
by Lawrence and Coleman may originate from the degree of
refinement and, in some cases, the resolution of the data of the
various models. The above values of Sc for the HyHEL-5–
lysozyme complex were calculated omitting the waters in the
model. If the 70 interface water molecules are included in the
calculation, Sc increases to 0.752.
3.2. Other features of the interface
When all waters are removed from the current high-
resolution structure, two solvent-inaccessible cavities are
found within the Fab–lysozyme interface and a third between
VL and VH. The total volume enclosed in the two cavities
located in the Fab–lysozyme interface is 108 A˚3. These two
cavities contain two water molecules each. The cavity between
VL and VH contains four waters in a volume of 121 A˚
3. In the
earlier lower resolution model of this complex, 3hfl, this third
cavity appeared to be joined to one of the cavities in the Fab–
lysozyme interface and the water content of the cavities could
not be fully defined. Three other small cavities are located
within the Fab and the lysozyme and are distant from the
interface.
Several interactions within the interface involve aromatic
rings. A 3.1 A˚ hydrogen bond is made from Wat387 to the
aromatic side chain of Trp91L (Fig. 1). The vector from the
center of the outer ring of the indole to Wat387 is 7.2 off the
ring perpendicular. A second water, Wat57, is buried just
below the surface of the Fab on the other side of the indole
ring, making a 3.4 A˚ hydrogen bond with this ring and an
angle of 4.9 to the ring perpendicular. Both of these waters
are positioned near the most optimal distance and angle in
relation to the indole ring for a water molecule to aromatic
ring hydrogen bond, yielding hydrogen bonds that are each
approximately half the strength of conventional hydrogen
bonds (Levitt & Perutz, 1988). In addition, N2 of Arg45 is
2.99 A˚ from Wat387 and 3.46 A˚ from the plane of the five-
member ring of Trp91L. The side chain of Arg68Y stacks
against the side chain of Trp33H with a separation of 3.5 A˚; the
planes of the Trp33H indole and the guanidinium group of
Arg68Y make an angle of approximately 7
 to each other.
4. Discussion
There is substantial evidence that water plays a significant role
in the formation of antibody–antigen complexes (Goldbaum et
al., 1996). Thermodynamic studies as well as crystallography
have demonstrated that the number of waters associated with
the complex can be greater or less than the number associated
with the isolated components. Whereas solvent molecules may
be excluded in regions of the complex interface that are highly
complementary, there are often some completely buried
waters as well as waters associated with the interface
periphery. In order to estimate by crystallographic means the
changes in bound waters upon formation of the complex, it is
necessary to know the waters associated with the complex and
with the two isolated components.
We have not been able to grow crystals of the uncomplexed
HyHEL-5 Fab molecule and therefore cannot obtain a direct
count of the number of water molecules bound at the paratope
of the uncomplexed antibody molecule. Consequently, the
water count must be estimated from an examination of other
antibody surfaces. The structure of the D44.1 antibody (PDB
code 1mlb; Braden et al., 1994) seemed to be an ideal source
for this information since this antibody is involved with nearly
the same epitope on lysozyme as HyHEL-5 Fab. However,
although the resolution of this structure is a reasonable 2.1 A˚,
the number of waters in the region of the uncomplexed
paratope is only 14. This appears to be too few waters in
comparison with the D1.3 Fv structure (PDB code 1vfa; Bhat
et al., 1994), which has 29 waters on its uncomplexed paratope
(Braden et al., 1994). The area of the D1.3 antibody paratope
is only 90% that of the D44.1 antibody paratope, but is
reported to have 60% more waters associated with it. We have
therefore chosen the 1vfa structure as the model with which to
estimate the number of waters bound to the HyHEL-5 para-
tope. This uncomplexed D1.3 binds 29 water molecules in the
vicinity of its lysozyme paratope and, since the area of the
HyHEL-5 paratope is about 20% larger than that of D1.3, we
estimate that 35 waters are located at the uncomplexed
HyHEL-5 paratope.
Table 2 lists seven PDB-deposited hen egg-white lysozyme
structures studied at approximately 100 K, as was the
HyHEL-5 complex with lysozyme, in the resolution range 1.5–
2.0 A˚ [PDB codes 1dpw and 1dpx (Weiss et al., 2000), 1gwd
(Evans & Bricogne, 2002), 1h87 (Girard et al., 2002), 1lz8
(Dauter et al., 1999), 1n4f (Retailleau & Prange´, 2003) and
1ps5 (Majeed et al., 2003)]. The number of waters within 3.5 A˚
of the epitope ranges from 38 to 63, with an average of 51. This
suggests that the minimum number of waters on the unbound
epitope for HyHEL-5 of lysozyme is at least 38 and may well
be somewhat closer to the average of 51.
The thermodynamic studies on the HyHEL-5 complex with
lysozyme by Xavier et al. (1997) suggest a net gain of 6–12
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Table 2
Solvation and intermolecular crystal contacts in the HyHEL-5 epitope
region of lysozyme structures studied at 100 K.
PDB
code
Temperature
(K) Waters Contacts
Resolution
(A˚)
Space
group
1dpw 100 50 18 1.64 P43212
1dpx 100 58 19 1.65 P43212
1gwd 100 38 17 1.77 P43212
1h87 100 59 17 1.72 P43212
1lz8 120 63 19 1.53 P43212
1n4f 100 42 20 1.78 P43212
1ps5 100 49 24 2.00 C2
Average 51.3  7.5 19.1  1.6
water molecules upon complex formation, implying that we
should find at least 79–85 waters in the complex interface. We
must note, however, that our structural results on the complex,
as well as the quoted results on the lysozyme structures, were
obtained at liquid-nitrogen temperature, under which condi-
tions we would expect more waters to be visible in the struc-
ture owing to the probable decrease in thermal parameters.
Because the D1.3 antibody structure was determined at room
temperature, we would expect an even larger number of
waters on its epitope if the results were also obtained at liquid-
nitrogen temperature, suggesting an even greater number of
waters to be found in the interface of the complex should a net
gain be observed. However, our structural results on the
HyHEL-5–lysozyme complex show only 70 waters in the
interface and its periphery. This is less than the conservative
sum of the waters on the epitope and paratope without any
gain upon complex formation. Within the limitations of the
available data, therefore, we find an apparent loss of waters in
the complex interface compared with the waters near the
uncomplexed surfaces. While part of this discrepancy might be
accounted for by the uncertainty in estimating the number of
waters on the isolated HyHEL-5, the result is not immediately
concordant with that of Xavier et al. (1997).
It should be kept in mind, however, that the measurements
of Xavier et al. (1997) were carried out in the presence of large
concentrations of osmolytes. It is possible that in the dehy-
drating osmolyte solution some waters which would be weakly
associated with free antibody and lysozyme in pure water are
absent or of lower occupancy. The osmolyte could also act to
dehydrate the complex, but the waters that we observe in the
crystallographic analysis would likely be relatively tightly
associated and less removable. The net effect would then be to
enhance the biophysically observed water uptake in compar-
ison to the crystallographically observed waters.
In their reassessment of the D1.3–lysozyme complex,
Braden et al. (1994) also note a loss rather than a gain in the
count of bound waters, contrary to the expectation from their
titration calorimetric studies of the D1.3–lysozyme associa-
tion. While noting the loss of water molecules upon forming
the D1.3–lysozyme complex, they also note that the shared
interface waters contribute a net increase in the total number
of hydrogen bonds within the interface. These water molecules
also fill what would be cavities within the complex interface if
the waters were not present. In the case of the HyHEL-5–
lysozyme complex, several residues of the lysozyme antigen
have undergone some small rearrangement in combining with
the Fab and it is likely that some antibody residues would also
have done so, but without a structure for the uncomplexed
antibody we cannot fully evaluate these factors. We find only a
few cavities in the interface, all of which are filled with waters.
There is, however, another major problem in determining
the number of water molecules on molecular surfaces as
observed in the crystal. The apparent number of waters bound
to the uncomplexed antibodies and antigens can be influenced
by hydrogen-bond or other close contacts between molecules
that arise from crystal packing. Such contacts are likely to
reduce the apparent number of waters at the unbound epitope
or paratope. Both the D1.3 and E8 Fabs as well as their
antigens exhibit this problem.
The D1.3 Fv structure shows ten hydrogen-bonding
contacts between the paratope and residues of neighboring
D1.3 Fv molecules in the crystal. In the seven lysozyme
structures referenced in Table 2, we find four to nine such
contacts from the D1.3 epitope to neighboring lysozyme
molecules in the crystal.
The complex of E8 Fab with cytochrome c antigen (PDB
code 1wej; Mylvaganam et al., 1998) appears to be in
reasonable agreement with their results of isothermal titration
calorimetry in comparison with the E8 Fab (PDB code 1qbl;
Mylvaganam et al., 1998) and the cytochrome c antigen (PDB
code 1hrc; Bushnell et al., 1990) that show a net loss of waters
in the complex. A loss of nine waters from the interface is
enumerated. Nevertheless, in the case of the cytochrome c
antibody structure 1qbl, there are ten paratope hydrogen-
bonding contacts with neighboring molecules in the crystal. In
the case of the cytochrome c crystal structure 1hrc, there are
four such contacts from the epitope region to neighboring
protein molecules.
From these three examples, we suggest that crystallographic
methods may not provide the most reliable estimate of the
number of water molecules that are bound to the protein
surfaces. Perhaps only methods such as isothermal titration
calorimetry are appropriate for this task since such methods
can evaluate the component molecules without the potential
of significant intermolecular contacts. The HyHEL-5–lyso-
zyme complex reported here, as well as the D1.3–lysozyme
complex and the E8–cytochrome c complex, all seem to
support this conclusion.
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